Europe Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)

Code: TIPRE00025452 | Pages: 127 | Industry: Pharmaceuticals | Date: Oct 2021
Covid

Market Introduction

Europe consists of five major countries namely Germany, the UK, France, Spain, and Italy. The market is also evaluated for the Rest of Europe market. The region holds second-largest position for the pharmaceutical intermediate market at a global level. The growth of the market is driven by increasing pharmaceutical production, growing innovations by biopharmaceutical companies, rising government support and development for the production facilities and infrastructures. The pharmaceutical intermediates market in the UK is primarily driven by government support. The government investments have broadly driven the productivity and activities and have allowed for the future fund, sustainable innovation funds to build the country’s pharmaceutical industry. The government has been continuously increasing in research and developments. The pharmaceutical industry in the UK is expected to be growing significantly in the coming future. The industry has shown its strength and sustainability during the global economic crises in 2020, caused due to COVID-19 pandemic. Increase in R&D investments by pharmaceutical companies is the major factor driving the growth of the Europe pharmaceutical intermediates market.

Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of coronavirus cases and deaths associated with it. As per the Worldometer as of April, 2021, in Spain, Italy, Germany, France, and UK, the number of cases is 3,370,256; 3,779,594; 3,021,064; 5,067,216; and 4,373,343 respectively and number of deaths are also high. Various companies have undergone severe losses in the last quarter of 2019 and have negatively impacted the year 2020. As to control the spread of disease, countries have imposed complete lockdown. The lockdown has resulted in slower economies due to closed trades and business.  The health and wellness market in Europe is observing steady growth due to the outbreak of coronavirus pandemic. Europeans are looking for different and natural ways of staying healthy and enhance their immune system. Lockdown and quarantine measures in Europe has led to a change in consumer buying habits. Some health categories are witnessing short-term decline in growth, while few are having positive effect on the sales of vitamins, dietary supplements, and analgesics with a strong focus on immunity and prevention. So, health supplements that were trending fine before the lockdown scenario have suddenly gained more attention as more consumers are looking for products that can help them in staying healthy. Multivitamins is one of the products that is gaining excellent popularity during pandemic. So, there is increased interest in how vitamins and health supplements can help people with their health and wellness in the coronavirus era. In France, specialist organic food shops have reported sales increases of over 40 percent. Holland & Barrett, the leading health food retailer in the UK, put a cap on supplement purchases due to its rising demand. Online retailer Healthspan reported that at end of March 2020, the sales of vitamin C supplements had tripled in a week. These factors are likely to have positive impact on the market growth.


Get more information on this report :



Market Overview and Dynamics

The pharmaceutical intermediates market in Europe is expected to grow from US$ 7,890.84 million in 2021 to US$ 10,135.51 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. Artificial intelligence (AI) is emerging as important tool as it helps understand the action mechanism of drugs. The use of AI tools has already been proven to accelerate the process of discovering new candidate therapeutics; the process that earlier used to take years for completion can now be accomplished within months using the AI. in addition to reducing the timelines of drug discovery, AI also helps enhance the agility of the research process, increase the accuracy of predictions on the efficacy and drug safety, and boost the speed and precision of discovery as well as preclinical testing, thereby enabling more competitive R&D strategies. Many of pharmaceutical players are collaborating with AI companies for drug discovery. For instance, In June 2017, Genentech collaborated with GNS Healthcare to use the proprietary REFS casual machine learning and simulation AI platform of the later to identify and validate novel cancer drug targets. Similarly, GlaxoSmithKline (GSK) collaborated with Insilico Medicine, a Baltimore-based AI-driven company, to explore the AI capability of Insilico for easing the process of identification of novel biological targets.

Key Market Segments

The Europe pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dextra Laboratories Limited; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; and Sanofi are among others.

Reasons to buy report

  • To understand the Europe pharmaceutical intermediates market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe pharmaceutical intermediates market
  • Efficiently plan M&A and partnership deals in Europe pharmaceutical intermediates market by identifying market segments with the most promising probable sales  
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe pharmaceutical intermediates market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Pharmaceutical Intermediates Market Segmentation

Europe Pharmaceutical Intermediates Market -By Type

  • GMP
  • Non GMP

Europe Pharmaceutical Intermediates Market -By Application

  • Antibiotics
  • Antipyretic analgesics
  • Vitamins
  • Others

Europe Pharmaceutical Intermediates Market -By Distribution Channel

  • Distributor
  • Direct Sales

Europe Pharmaceutical Intermediates Market -By Country

  • Germany
  • France
  • Italy
  • United Kingdom
  • Spain
  • Rest of Europe

Europe Pharmaceutical Intermediates Market -Company Profiles

  • BASF SE
  • chiracon GmbH
  • Codexis
  • Dextra Laboratories Limited
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Sanofi

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Pharmaceutical Intermediates Market – By Type

1.3.2        Europe Pharmaceutical Intermediates Market – By Application

1.3.3        Europe Pharmaceutical Intermediates Market – By Distribution Channel

1.3.4        Europe Pharmaceutical Intermediates Market– By Country

2.           Pharmaceutical Intermediates Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Pharmaceutical Intermediates Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Pharmaceutical Intermediates Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Diseases and Infectious Diseases

5.1.2        Increase in R&D Investments by Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Cost of Manufacturing

5.3         Market Opportunities

5.3.1        Emerging Markets

5.4         Future Trends

5.4.1        Increasing Adoption of AI-based Tools for Drug Discovery

5.5         Impact Analysis

6.           Pharmaceutical Intermediates Market– Europe Analysis

6.1         Europe Pharmaceutical Intermediates Market Revenue Forecast and Analysis

7.           Europe Pharmaceutical Intermediates Market Analysis – By Type

7.1         Overview

7.2         Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

7.3         GMP

7.3.1        Overview

7.3.2        GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Non GMP

7.4.1        Overview

7.4.2        Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.           Europe Pharmaceutical Intermediates Market Analysis – By Application

8.1         Overview

8.2         Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

8.3         Antibiotics

8.3.1        Overview

8.3.2        Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Antipyretic Analgesics

8.4.1        Overview

8.4.2        Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Vitamins

8.5.1        Overview

8.5.2        Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Other

8.6.1        Overview

8.6.2        Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Pharmaceutical Intermediates Market– By Distribution Channel

9.1         Overview

9.2         Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

9.3         Distributor

9.3.1        Overview

9.3.2        Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Direct Sales

9.4.1        Overview

9.4.2        Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

10.        Europe Pharmaceutical Intermediates Market – Country Analysis

10.1.1     Overview

10.1.2     Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.1.3     Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1       Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2       Germany: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.3.3       Germany: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.3.4       Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.4     UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1       UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2       UK: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.4.3       UK: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.4.4       UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.5     France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1       France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2       France: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.5.3       France: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.5.4       France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6     Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1       Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2       Spain: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.6.3       Spain: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.6.4       Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.7     Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1       Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2       Italy: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.7.3       Italy: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.7.4       Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.8     Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1       Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2       Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.8.3       Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.8.4       Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on Europe Pharmaceutical Intermediates Market

11.1      Overview

12.        Europe Pharmaceutical Intermediates Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Pfizer Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Sanofi

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BASF SE

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dishman Carbogen Amcis Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Codexis

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Midas Pharma GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      chiracon GmbH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Dextra Laboratories Limited

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 5.             UK Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             UK Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             UK Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             France Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             France Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          France Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Spain Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Spain Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          Spain Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14.          Italy Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Italy Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Italy Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 20.          Organic Developments Done By Companies

Table 21.          Inorganic Developments Done By Companies

Table 22.          Glossary of Terms, Europe Pharmaceutical Intermediates Market

LIST OF FIGURES

Figure 1.           Europe Pharmaceutical Intermediates Market Segmentation

Figure 2.           Europe Pharmaceutical Intermediates Segmentation, By Country

Figure 3.           Europe Pharmaceutical Intermediates Market Overview

Figure 4.           GMP Held Largest Share of Type Segment in Europe Pharmaceutical Intermediates Market

Figure 5.           UK to Show Remarkable Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Europe Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints

Figure 9.           Europe Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        Europe Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

Figure 11.        Europe GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

Figure 14.        Europe Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

Figure 19.        Europe Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 22.        Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 23.        Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic in European Country Markets

  1. BASF SE
  2. chiracon GmbH
  3. Codexis
  4. Dextra Laboratories Limited
  5. Dishman Carbogen Amcis Ltd
  6. Midas Pharma GmbH
  7. Pfizer Inc.
  8. Sanofi
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Pharmaceutical Intermediates market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Pharmaceutical Intermediates market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Pharmaceutical Intermediates market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags Europe Pharmaceutical Intermediates Market Europe Pharmaceutical Intermediates Market Research Europe Pharmaceutical Intermediates Market Insight Europe Pharmaceutical Intermediates Market Trends Europe Pharmaceutical Intermediates Market Forecast Europe Pharmaceutical Intermediates Market Share Europe Pharmaceutical Intermediates Market 2028 Europe Pharmaceutical Intermediates Market Growth Europe Pharmaceutical Intermediates Industry Sector Europe Pharmaceutical Intermediates PDF Report Europe Pharmaceutical Intermediates Analysis Europe Pharmaceutical Intermediates Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000